Arthritis is the ultimate growth industry. Today we focus on The Arthritis Treatment Centers, a branch of HealthSonix.
Projected Rise in Arthritis Prevalence — The Center for Disease Control indicates that by 2030, nearly 67 million (25%) of US adults will have doctor-diagnosed arthritis. In addition, adults with arthritis-attributable activity limitation are projected to increase from 16.9 million (7.9%) to 25 million (9.3% of the US adult population) by 2030. These projections herald an increasing societal and health care system burden.
HealthSonix provides information to patients looking for answers. Today’s babyboomers are computer literate and in fact are the generation that invented the computer. This website is designed to appeal to this generation. As HealthSonix notes at its website: Arthritis Treatment Centers of America “The guidelines published by the American College of Rheumatology recommend the use of nonpharmacologic therapies as a first line of defense against arthritis.”
Through this information based website focusing on arthritis HealthSonix is able to individually address each patient’s need and take the time necessary to provide insight and solutions to their issues concerning arthritic pain.
HealthSonix staffs its call center with healthcare professionals who are trained to offer an integrated approach to arthritis care. They address arthritis issues and solutions involving: Physical and Occupational Therapy; Rheumatology Rehabilitation; Kinesiology; Psychology; and Nutrition.
The Arthritis Treatment Center is designed to promote wellness through a warm and welcoming environment. The have used extensive patient feed back to help them design many of the amenities that make each visit or call a pleasant and rewarding experience.
This is also an excellent forum for detailing the benefits of ensonix @ home –http://www.healthsonix.com/ensonixtherapy.com/ — the newly released device which provides sound pressure wave therapy similar to that used in the Centers.
Stay tuned for more on this company that provides relief to an achey body!
Sources:
HealthSonix Inc.
14252 Culver Drive
Suite 107
Irvine CA 92604-0317
Tel: (949)417-8880
Fax: (949)271-3760
www.HealthSonix.com
About HealthSonix Inc.: HealthSonix Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) is a publicly traded medical technology company. The Company’s core offerings are based on proprietary, patent pending medical technologies that use sound pressure waves to administer sub-sensory micro vibration to the human body. Precisely formatted low frequency sound pressure waves are 80% effective in treating the pain of many diseases, particularly arthritis. All treatments and products are safe, non-invasive, drug free, and have no known side effects.
Forward Loooking Statement: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com .
Disclosure: Pentony Enterprises LLC was compensated $12,500 from a non-controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.